While schedules vary depending on the specific drug, the principle remains the same
its evidence comes from the STEP program, and it also carries an FDA indication to reduce cardiovascular events in adults with established cardiovascular disease plus obesity or overweight
Medicare, Medicaid start obesity pilot program in mid-2026
Heres how dosing compares: Semaglutide Wegovy (injection): Taken once weekly, starting at 0.25 mg once and gradually increased as needed but not earlier than every 4 weeks, up to 7.2 mg, as needed
CagriSema combines cagrilintide with semaglutide for enhanced efficacy
Copper peptides and DHT Most people reading this have pattern hair loss, which is driven largely by dihydrotestosterone (DHT), a hormone that gradually shrinks genetically susceptible follicles